Literature DB >> 20075243

How the noninflammasome NLRs function in the innate immune system.

Jenny P Y Ting1, Joseph A Duncan, Yu Lei.   

Abstract

NLR (nucleotide-binding domain, leucine-rich repeat-containing) proteins have rapidly emerged as central regulators of immunity and inflammation with demonstrated relevance to human diseases. Much attention has focused on the ability of several NLRs to activate the inflammasome complex and drive proteolytic processing of inflammatory cytokines; however, NLRs also regulate important inflammasome-independent functions in the immune system. We discuss several of these functions, including the regulation of canonical and noncanonical NF-kappaB activation, mitogen-activated protein kinase activation, cytokine and chemokine production, antimicrobial reactive oxygen species production, type I interferon production, and ribonuclease L activity. We also explore the mechanistic basis of these functions and describe current challenges in the field.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20075243      PMCID: PMC3943909          DOI: 10.1126/science.1184004

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  46 in total

1.  Mitofusin 2 inhibits mitochondrial antiviral signaling.

Authors:  Kai Yasukawa; Hiroyuki Oshiumi; Makoto Takeda; Naotada Ishihara; Yusuke Yanagi; Tsukasa Seya; Shun-ichiro Kawabata; Takumi Koshiba
Journal:  Sci Signal       Date:  2009-08-18       Impact factor: 8.192

2.  An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix.

Authors:  Damien Arnoult; Fraser Soares; Ivan Tattoli; Céline Castanier; Dana J Philpott; Stephen E Girardin
Journal:  J Cell Sci       Date:  2009-09-01       Impact factor: 5.285

3.  DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses.

Authors:  Simone Lipinski; Andreas Till; Christian Sina; Alexander Arlt; Helmut Grasberger; Stefan Schreiber; Philip Rosenstiel
Journal:  J Cell Sci       Date:  2009-10-01       Impact factor: 5.285

4.  A Crohn's disease-associated NOD2 mutation suppresses transcription of human IL10 by inhibiting activity of the nuclear ribonucleoprotein hnRNP-A1.

Authors:  Eiichiro Noguchi; Yoichiro Homma; Xiaoyan Kang; Mihai G Netea; Xiaojing Ma
Journal:  Nat Immunol       Date:  2009-04-06       Impact factor: 25.606

5.  A NOD2-NALP1 complex mediates caspase-1-dependent IL-1beta secretion in response to Bacillus anthracis infection and muramyl dipeptide.

Authors:  Li-Chung Hsu; Syed R Ali; Shauna McGillivray; Ping-Hui Tseng; Sanjeev Mariathasan; Eric W Humke; Lars Eckmann; Jonathan J Powell; Victor Nizet; Vishva M Dixit; Michael Karin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-29       Impact factor: 11.205

6.  Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.

Authors:  L A Simms; J D Doecke; M D Walsh; N Huang; E V Fowler; G L Radford-Smith
Journal:  Gut       Date:  2008-02-27       Impact factor: 23.059

7.  Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2.

Authors:  Mathieu J M Bertrand; Karine Doiron; Katherine Labbé; Robert G Korneluk; Philip A Barker; Maya Saleh
Journal:  Immunity       Date:  2009-05-21       Impact factor: 31.745

8.  Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria.

Authors:  Lijuan Xu; Nengming Xiao; Feng Liu; Hongwei Ren; Jun Gu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

9.  Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Authors:  François Coulombe; Maziar Divangahi; Frédéric Veyrier; Louis de Léséleuc; James L Gleason; Yibin Yang; Michelle A Kelliher; Amit K Pandey; Christopher M Sassetti; Michael B Reed; Marcel A Behr
Journal:  J Exp Med       Date:  2009-07-06       Impact factor: 14.307

10.  MAVS-mediated apoptosis and its inhibition by viral proteins.

Authors:  Yu Lei; Chris B Moore; Rachael M Liesman; Brian P O'Connor; Daniel T Bergstralh; Zhijian J Chen; Raymond J Pickles; Jenny P-Y Ting
Journal:  PLoS One       Date:  2009-03-07       Impact factor: 3.240

View more
  128 in total

1.  Crohn's disease risk alleles on the NOD2 locus have been maintained by natural selection on standing variation.

Authors:  Shigeki Nakagome; Shuhei Mano; Lukasz Kozlowski; Janusz M Bujnicki; Hiroki Shibata; Yasuaki Fukumaki; Judith R Kidd; Kenneth K Kidd; Shoji Kawamura; Hiroki Oota
Journal:  Mol Biol Evol       Date:  2012-01-12       Impact factor: 16.240

2.  NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists.

Authors:  Anne Månsson Kvarnhammar; Terese Petterson; Lars-Olaf Cardell
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

Review 3.  Programming dendritic cells to induce T(H)2 and tolerogenic responses.

Authors:  Bali Pulendran; Hua Tang; Santhakumar Manicassamy
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 4.  Immunogenomics and systems biology of vaccines.

Authors:  Luigi Buonaguro; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

Review 5.  New insights into the role of RNase L in innate immunity.

Authors:  Arindam Chakrabarti; Babal Kant Jha; Robert H Silverman
Journal:  J Interferon Cytokine Res       Date:  2010-12-29       Impact factor: 2.607

6.  Cutting edge: NLRC5-dependent activation of the inflammasome.

Authors:  Beckley K Davis; Reid A Roberts; Max T Huang; Stephen B Willingham; Brian J Conti; W June Brickey; Brianne R Barker; Mildred Kwan; Debra J Taxman; Mary-Ann Accavitti-Loper; Joseph A Duncan; Jenny P-Y Ting
Journal:  J Immunol       Date:  2010-12-29       Impact factor: 5.422

Review 7.  Accessory molecules for Toll-like receptors and their function.

Authors:  Clarissa C Lee; Ana M Avalos; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2012-02-03       Impact factor: 53.106

Review 8.  Cross-regulation between the IL-1β/IL-18 processing inflammasome and other inflammatory cytokines.

Authors:  Brianne R Barker; Debra J Taxman; Jenny P-Y Ting
Journal:  Curr Opin Immunol       Date:  2011-08-10       Impact factor: 7.486

9.  Differential Peptidoglycan Recognition Assay Using Varied Surface Presentations.

Authors:  Elizabeth A D'Ambrosio; Klare L Bersch; Mackenzie L Lauro; Catherine L Grimes
Journal:  J Am Chem Soc       Date:  2020-06-16       Impact factor: 15.419

Review 10.  Innate antiviral immune signaling, viral evasion and modulation by HIV-1.

Authors:  Arjun Rustagi; Michael Gale
Journal:  J Mol Biol       Date:  2013-12-08       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.